Zimmer Biomet has had a hectic year, with 10-year veteran David Dvorak abruptly stepping away from the corner office in July and senior VP and CFO Daniel Florin stepping in until a replacement is found.
Dvorak hasn’t been the only employee to exit the company, which said it “cleaned house” at certain Warsaw-based facilities after receiving a number of violations during an FDA inspection.
The purge included replacing the company’s senior vice president of global operations and logistics, vice president of quality assurance at all of its Warsaw sites, the quality assurance director for its North Campus facilities, the compliance director for the Biomet network, and the quality assurance director for post-market surveillance and complaint handling.
Featured Articles & Products Read More >
Zimmer Biomet (NYSE:ZBH) today announced additional responsibilities for Investor Relations SVP and Chief Communications Officer Keri Mattox. Mattox’s new title at the Warsaw, Indiana-based orthopedics company is chief communications and administration officer. She will be responsible for “building and executing a comprehensive strategy around Environmental, Social and Governance (ESG) initiatives and increasing CEO visibility, engagement… [Read More]
An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… [Read More]
Everyone has a story about how they got into medtech, and it’s no surprise that many of those stories start with how we were raised. As Mother’s Day approaches, Medical Design & Outsourcing asked medtech leaders to share some thoughts about how their moms inspired their careers, the products they make and the companies they’ve… [Read More]